Cell and gene therapy: a snapshot of investor perspectives-Reference-Cited by-同舟云学术

Cell and gene therapy: a snapshot of investor perspectives

Published:2021-03 Issue:3 Volume:23 Page:256-260
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Moody Jennifer,Milligan William D.,St. Onge Madeline,Goonewardene Asthika,Rivers Patrick

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference6 articles.

1. Alliance for Regenerative Medicine. Advancing Gene, Cell & Tissue Based Therapies. 2019 ARM Annual Report & Sector Year in Review, https://alliancerm.org/sector-report/2019-annual-report; 2020 [accessed November 6, 2020].

2. The global pipeline of cell therapies for cancer;Nature Drug Discovery,2019

3. Estimating the Clinical Pipeline of Cell and Gene Therapies and Their Potential Economic Impact on the US Healthcare System;Value Health,2019

4. Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management;Blood Rev,2019

5. The long road to the first FDA approved gene therapy: chimeric antigen receptor T cells targeting CD19;Cytotherapy,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and opportunities for access to Advanced Therapy Medicinal Products in Brazil;Cytotherapy;2024-08

2. Cell and gene therapy investment: evolution and future outlook on investor perspectives;Cytotherapy;2024-07

3. Manufacturing Cell and Gene Therapies: Challenges in Clinical Translation;Annals of Laboratory Medicine;2024-02-16

4. The Art of Stem Cell-Based Therapy;Potency Assays for Advanced Stem Cell Therapy Medicinal Products;2023

5. Regulatory Environment and Approvals in Cell and Gene Therapy Products Between Japan, the USA, and the EU;Therapeutic Innovation & Regulatory Science;2022-09-16